Cargando…
Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453467/ https://www.ncbi.nlm.nih.gov/pubmed/34548632 http://dx.doi.org/10.1038/s41390-021-01744-8 |
| _version_ | 1784570278348587008 |
|---|---|
| author | Sinha, Rajiv Marlais, Matko Sarkar, Subhankar Obukhova, Varvara Lucchetti, Laura Vasudevan, Anil Chacon Jaimes, Diana Carolina Weaver, Donald J. Stańczyk, Małgorzata Lopez-Gonzalez, Mercedes Schaefer, Franz Tullus, Kjell |
| author_facet | Sinha, Rajiv Marlais, Matko Sarkar, Subhankar Obukhova, Varvara Lucchetti, Laura Vasudevan, Anil Chacon Jaimes, Diana Carolina Weaver, Donald J. Stańczyk, Małgorzata Lopez-Gonzalez, Mercedes Schaefer, Franz Tullus, Kjell |
| author_sort | Sinha, Rajiv |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8453467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84534672021-09-21 Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome Sinha, Rajiv Marlais, Matko Sarkar, Subhankar Obukhova, Varvara Lucchetti, Laura Vasudevan, Anil Chacon Jaimes, Diana Carolina Weaver, Donald J. Stańczyk, Małgorzata Lopez-Gonzalez, Mercedes Schaefer, Franz Tullus, Kjell Pediatr Res Correspondence Nature Publishing Group US 2021-09-21 2022 /pmc/articles/PMC8453467/ /pubmed/34548632 http://dx.doi.org/10.1038/s41390-021-01744-8 Text en © The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Sinha, Rajiv Marlais, Matko Sarkar, Subhankar Obukhova, Varvara Lucchetti, Laura Vasudevan, Anil Chacon Jaimes, Diana Carolina Weaver, Donald J. Stańczyk, Małgorzata Lopez-Gonzalez, Mercedes Schaefer, Franz Tullus, Kjell Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title | Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title_full | Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title_fullStr | Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title_full_unstemmed | Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title_short | Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| title_sort | impact of covid-19 pandemic on use of rituximab among children with difficult nephrotic syndrome |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453467/ https://www.ncbi.nlm.nih.gov/pubmed/34548632 http://dx.doi.org/10.1038/s41390-021-01744-8 |
| work_keys_str_mv | AT sinharajiv impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT marlaismatko impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT sarkarsubhankar impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT obukhovavarvara impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT lucchettilaura impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT vasudevananil impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT chaconjaimesdianacarolina impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT weaverdonaldj impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT stanczykmałgorzata impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT lopezgonzalezmercedes impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT schaeferfranz impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome AT tulluskjell impactofcovid19pandemiconuseofrituximabamongchildrenwithdifficultnephroticsyndrome |